AAAAAA

   
Results: 1-22 |
Results: 22
AUGMENTED MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) MMP-2 MESSENGER-RNA RATIO IN GASTRIC CARCINOMAS WITH POOR-PROGNOSIS/
Authors: CAENAZZO C ONISTO M SARTOR L SCALERTA R GIRALDO A NITTI D GARBISA S
Citation: C. Caenazzo et al., AUGMENTED MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE (MT1-MMP) MMP-2 MESSENGER-RNA RATIO IN GASTRIC CARCINOMAS WITH POOR-PROGNOSIS/, Clinical cancer research, 4(9), 1998, pp. 2179-2186
NUCLEAR P53 PROTEIN EXPRESSION IN RESECTED HEPATIC METASTASES FROM COLORECTAL-CANCER - AN INDEPENDENT PROGNOSTIC FACTOR OF SURVIVAL
Authors: NITTI D BELLUCO C MONTESCO MC BERTORELLE R DAPIAN PP FASSINA A NINFO V CHIECOBIANCHI L LISE M
Citation: D. Nitti et al., NUCLEAR P53 PROTEIN EXPRESSION IN RESECTED HEPATIC METASTASES FROM COLORECTAL-CANCER - AN INDEPENDENT PROGNOSTIC FACTOR OF SURVIVAL, European journal of cancer, 34(6), 1998, pp. 851-855
EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL
Authors: GRIMALDI C BLEIBERG H GAY F MESSNER M ROUGIER P KOK TC CIRERA L CERVANTES A DEGREVE J PAILLOT B BUSET M NITTI D SAHMOUD T DUEZ N WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG
Authors: WILS J SAHMOUD T SOBRERO A BLEIBERG H AHMEDZAI S BLAZEBY J BLIJHAM G CONROY T CUNNINGHAM D CURRAN D DIAZRUBIO E DUCREUX M EVANS J GLIMELIUS B HUTCHINSON G KERR D KIEBERT G KOHNE H LABIANCA R LANGENDIJK R NITTI D NORDLINGER B ROUGIER P SCHEITHAUER W SCHMOLL HJ VANCUTSEM E WAGENER T WILKE J MARINUS A THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL
Authors: ROUGIER P SAHMOUD T NITTI D CURRAN D DOCI R DEWAELE B NAKAJIMA T RAUSCHECKER H LABIANCA R PECTOR JC MARSONI S APOLONE G LASSER P COUVREUR ML WILS J
Citation: P. Rougier et al., ADJUVANT PORTAL-VEIN INFUSION OF FLUOROURACIL AND HEPARIN IN COLORECTAL-CANCER - A RANDOMIZED TRIAL, Lancet, 351(9117), 1998, pp. 1677-1681
HEPATITIS-C VIRUS-INFECTION ASSOCIATED WITH HUMAN HEPATOCELLULAR-CARCINOMA - LACK OF CORRELATION WITH P53 ABNORMALITIES IN CAUCASIAN PATIENTS
Authors: PONTISSO P BELLUCO C BERTORELLE R DEMOLINER L CHIECOBIANCHI L NITTI D LISE M ALBERTI A
Citation: P. Pontisso et al., HEPATITIS-C VIRUS-INFECTION ASSOCIATED WITH HUMAN HEPATOCELLULAR-CARCINOMA - LACK OF CORRELATION WITH P53 ABNORMALITIES IN CAUCASIAN PATIENTS, Cancer, 83(8), 1998, pp. 1489-1494
PROGNOSTIC FACTORS AFFECTING LONG-TERM OUTCOME AFTER LIVER RESECTION FOR HEPATOCELLULAR-CARCINOMA - RESULTS IN SERIES OF 100 ITALIAN PATIENTS
Authors: LISE M BACCHETTI S DAPIAN P NITTI D PILATI PL PIGATO P
Citation: M. Lise et al., PROGNOSTIC FACTORS AFFECTING LONG-TERM OUTCOME AFTER LIVER RESECTION FOR HEPATOCELLULAR-CARCINOMA - RESULTS IN SERIES OF 100 ITALIAN PATIENTS, Cancer, 82(6), 1998, pp. 1028-1036
FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987)
Authors: NITTI D WILS J SAHMOUD T CURRAN D COUVREUR ML LISE M RAUSCHECKER H DOSSANTOS JG STREMMEL W ROELOFSEN F
Citation: D. Nitti et al., FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL ON ADJUVANT INTRAPORTAL INFUSION WITH HEPARIN AND 5-FLUOROURACIL (5-FU) IN RESECTABLE COLON-CANCER (EORTC GITCCG 1983-1987), European journal of cancer, 33(8), 1997, pp. 1209-1215
RESECTION OF PULMONARY METASTASES FROM COLORECTAL-CARCINOMA
Authors: ZANELLA A MARCHET A MAINENTE P NITTI D LISE M
Citation: A. Zanella et al., RESECTION OF PULMONARY METASTASES FROM COLORECTAL-CARCINOMA, European journal of surgical oncology, 23(5), 1997, pp. 424-427
P53 GENE ALTERATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER
Authors: BERTORELLE R ESPOSITO G BELLUCO C BONALDI L DELMISTRO A NITTI D LISE M CHIECOBIANCHI L
Citation: R. Bertorelle et al., P53 GENE ALTERATIONS AND PROTEIN ACCUMULATION IN COLORECTAL-CANCER, JCP. Clinical molecular pathology, 49(2), 1996, pp. 85-90
PULMONARY LYMPHANGIOLEIOMYOMATOSIS - A CASE-REPORT IN POSTMENOPAUSAL WOMAN TREATED WITH PLEURODESIS AND PROGESTERONE (MEDROXYPROGESTERONE ACETATE)
Authors: ZANELLA A TOPPAN P NITTI D LISE M
Citation: A. Zanella et al., PULMONARY LYMPHANGIOLEIOMYOMATOSIS - A CASE-REPORT IN POSTMENOPAUSAL WOMAN TREATED WITH PLEURODESIS AND PROGESTERONE (MEDROXYPROGESTERONE ACETATE), Tumori, 82(1), 1996, pp. 96-98
INCREASED LEVELS OF CATHEPSIN-B AND CATHEPSIN-L, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR TYPE-1 AS AN EARLY EVENT IN GASTRICCARCINOGENESIS
Authors: FARINATI F HERSZENYI L PLEBANI M CARRARO P DEPAOLI M CARDIN R ROVERONI G RUGGE M NITTI D GRIGIONI WF DERRICO A NACCARATO R
Citation: F. Farinati et al., INCREASED LEVELS OF CATHEPSIN-B AND CATHEPSIN-L, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR TYPE-1 AS AN EARLY EVENT IN GASTRICCARCINOGENESIS, Carcinogenesis, 17(12), 1996, pp. 2581-2587
PROGNOSTIC FACTORS IN RESECTABLE GASTRIC-CANCER - RESULTS OF EORTC STUDY NO-40813 ON FAM ADJUVANT CHEMOTHERAPY
Authors: LISE M NITTI D MARCHET A SAHMOUND T DUEZ N FORNASIERO A DOSSANTOS JG LABIANCA R LASSER P GIGNOUX M
Citation: M. Lise et al., PROGNOSTIC FACTORS IN RESECTABLE GASTRIC-CANCER - RESULTS OF EORTC STUDY NO-40813 ON FAM ADJUVANT CHEMOTHERAPY, Annals of surgical oncology, 2(6), 1995, pp. 495-501
FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL OF ADJUVANT CHEMOTHERAPY WITH THE MODIFIED FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN REGIMEN IN RESECTABLE GASTRIC-CANCER
Authors: LISE M NITTI D MARCHET A SAHMOUD T BUYSE M DUEZ N FIORENTINO M DOSSANTOS JG LABIANCA R ROUGIER P GIGNOUX M
Citation: M. Lise et al., FINAL RESULTS OF A PHASE-III CLINICAL-TRIAL OF ADJUVANT CHEMOTHERAPY WITH THE MODIFIED FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN REGIMEN IN RESECTABLE GASTRIC-CANCER, Journal of clinical oncology, 13(11), 1995, pp. 2757-2763
ASSOCIATION OF P53 GENE AND PROTEIN ALTERATIONS WITH METASTASES IN COLORECTAL-CANCER
Authors: BERTORELLE R ESPOSITO G DELMISTRO A BELLUCO C NITTI D LISE M CHIECOBIANCHI L
Citation: R. Bertorelle et al., ASSOCIATION OF P53 GENE AND PROTEIN ALTERATIONS WITH METASTASES IN COLORECTAL-CANCER, The American journal of surgical pathology, 19(4), 1995, pp. 463-471
CYSTEINE AND SERINE PROTEASES IN GASTRIC-CANCER
Authors: PLEBANI M HERSZENYI L CARDIN R ROVERONI G CARRARO P PAOLI MD RUGGE M GRIGIONI WF NITTI D NACCARATO R FARINATI F
Citation: M. Plebani et al., CYSTEINE AND SERINE PROTEASES IN GASTRIC-CANCER, Cancer, 76(3), 1995, pp. 367-375
TUMOR-INFILTRATING LYMPHOCYTES BEAR THE 75-KDA TUMOR-NECROSIS-FACTOR RECEPTOR
Authors: TRENTIN L ZAMBELLO R BULIAN P CERUTTI A ENTHAMMER C CASSATELLA M NITTI D LISE M AGOSTINI C SEMENZATO G
Citation: L. Trentin et al., TUMOR-INFILTRATING LYMPHOCYTES BEAR THE 75-KDA TUMOR-NECROSIS-FACTOR RECEPTOR, British Journal of Cancer, 71(2), 1995, pp. 240-245
INTRAOPERATIVE CYTOLOGY OF PANCREATIC MASSES - A 10-YEAR EXPERIENCE
Authors: BLANDAMURA S COSTANTIN G NITTI D BOCCATO P
Citation: S. Blandamura et al., INTRAOPERATIVE CYTOLOGY OF PANCREATIC MASSES - A 10-YEAR EXPERIENCE, Acta cytologica, 39(1), 1995, pp. 23-27
COFFEE CONSUMPTION AND PANCREATIC-CANCER - A CANCER-CONTROLLED CASE-CONTROL STUDY
Authors: FARINATI F DELLALIBERA G VALIANTE F TANDUO C DEMARIA N MARAFIN C ANGONESE C NITTI D BARDINI R TROPEA A DELFAVERO G NACCARATO R
Citation: F. Farinati et al., COFFEE CONSUMPTION AND PANCREATIC-CANCER - A CANCER-CONTROLLED CASE-CONTROL STUDY, European journal of gastroenterology & hepatology, 6(2), 1994, pp. 189-190
PHASE-II STUDY ON NEOADJUVANT HYPERTHERMIC-ANTIBLASTIC PERFUSION WITHDOXORUBICIN IN PATIENTS WITH INTERMEDIATE OR HIGH-GRADE LIMB SARCOMAS
Authors: ROSSI CA VECCHIATO A FOLETTO M NITTI D NINFO V FORNASIERO A SOTTI G TREGNAGHI A MELANOTTE P LISE M
Citation: Ca. Rossi et al., PHASE-II STUDY ON NEOADJUVANT HYPERTHERMIC-ANTIBLASTIC PERFUSION WITHDOXORUBICIN IN PATIENTS WITH INTERMEDIATE OR HIGH-GRADE LIMB SARCOMAS, Cancer, 73(8), 1994, pp. 2140-2146
PATHOLOGY AND PLOIDY IN THE PROGNOSIS OF GASTRIC-CANCER WITH NO EXTRANODAL METASTASIS
Authors: RUGGE M SONEGO F PANOZZO M BAFFA R RUBIO J FARINATI F NITTI D NINFO V MING SC
Citation: M. Rugge et al., PATHOLOGY AND PLOIDY IN THE PROGNOSIS OF GASTRIC-CANCER WITH NO EXTRANODAL METASTASIS, Cancer, 73(4), 1994, pp. 1127-1133
FUNCTIONAL-ROLE OF IL-2 RECEPTORS ON TUMOR-INFILTRATING LYMPHOCYTES
Authors: TRENTIN L ZAMBELLO R BULIAN P CERUTTI A MILANI A PIRONE E NITTI D AGOSTINI C SEMENZATO G
Citation: L. Trentin et al., FUNCTIONAL-ROLE OF IL-2 RECEPTORS ON TUMOR-INFILTRATING LYMPHOCYTES, British Journal of Cancer, 69(6), 1994, pp. 1046-1051
Risultati: 1-22 |